STEALTH-001
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics
Pfizer
Tizona Therapeutics, Inc
University of Nebraska
Takeda
Kidney Cancer Research Bureau
Adela, Inc
Second Life Therapeutics
Elephas
Novartis
Elephas
University of Pittsburgh
Degron Therapeutics Co.
University Health Network, Toronto
National Institutes of Health Clinical Center (CC)
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
The University of Texas Health Science Center at San Antonio
A2 Biotherapeutics Inc.
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Delfi Diagnostics Inc.
A2 Biotherapeutics Inc.
Genentech, Inc.
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
University of Alabama at Birmingham
Cancer Research UK
DEKA Biosciences
Columbia University
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Elevation Oncology
RenJi Hospital
Sheffield Teaching Hospitals NHS Foundation Trust
University Health Network, Toronto
Rutgers, The State University of New Jersey
Universidade Federal de Pernambuco
Taproot Health
Inhibrx Biosciences, Inc
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
European Organisation for Research and Treatment of Cancer - EORTC
University of Sydney
Second Affiliated Hospital of Guangzhou Medical University
Washington University School of Medicine
Cedars-Sinai Medical Center
Celldex Therapeutics
Hospices Civils de Lyon
Corvus Pharmaceuticals, Inc.
Shanghai Yunying Medical Technology